Articles related to Clinical Research

< back to service

NAD Recommends that Medical Device Manufacturer Discontinue Advertising Claims Following Competitor Challenge

[07/11/24]

Preparing for Change: After 20 Years, HHS Proposes Update to Research Misconduct Regulations 

[02/16/24]

A Whole New World for Laboratory Developed Tests – FDA Proposes End to Its Longstanding Policy of Enforcement Discretion

[11/30/23]

FDA Finalizes Its Informed Consent Guidance for IRBs, Clinical Investigators and Sponsors

[10/05/23]

FDA Outlines Considerations for Conducting Clinical Investigations Using Psychedelic Drugs

[09/15/23]

Embracing Technology: FDA Releases Draft Guidance on Decentralized Clinical Trials

[09/14/23]

U.S. Food and Drug Administration Issues Draft Guidance Updating Good Clinical Practices 

[06/29/23]

Single Institutional Review Board Exception Determination Set to Expire May 11, 2023

[03/01/23]

Important Information for COVID-19 Vaccine Providers

[12/15/20]

Substance Use Disorder Providers Should Note SAMHSA Proposed Changes to 42 CFR Part 2

[08/30/19]

The Practice of Medicine vs. Protecting Patient Safety: Groundbreaking Court Ruling in Support of the FDA’s Regulation of Certain Stem Cell Therapies

[06/11/19]

Delay of “2018 Requirements” that Revise the Common Rule

[04/04/18]

New Guidance: FDA Allows Waiver of Informed Consent for Minimal Risk Research

[08/22/17]

CMS Proposes Significant Changes to the CJR Model and the Cancellation of the AMI, CABG and SHFFT Episode Payment Models

[08/16/17]

OIG Approves Waiver of Cost-Sharing Amounts for Financially Needy Beneficiaries Participating in Clinical Research Studies

[07/18/17]